BAMS
Bellevue Asset Management (Switzerland) Portfolio holdings
AUM
$656M
This Quarter Return
+12.16%
1 Year Return
+11.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$717M
AUM Growth
–
Cap. Flow
+$717M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
28.86%
Holding
141
New
140
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Biogen
BIIB
|
$29.9M |
| 2 |
Medtronic
MDT
|
$26.5M |
| 3 |
CELG
Celgene Corp
CELG
|
$26M |
| 4 |
Abbott
ABT
|
$23.5M |
| 5 |
Gilead Sciences
GILD
|
$22.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 85.27% |
| 2 | Financials | 0.88% |
| 3 | Industrials | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
THOR
76
DELISTED
THORATEC CORPORATION
THOR
| $2.3M | 0.32% |
+55,000
| New | +$2.3M |
|
77
Merck
MRK
$210B
| $2.3M | 0.32% |
+40,000
| New | +$2.3M |
|
|
INFI
78
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $2.29M | 0.32% |
+164,000
| New | +$2.29M |
|
79
Globus Medical
GMED
$8.27B
| $2.27M | 0.32% |
+90,000
| New | +$2.27M |
|
|
ATHN
80
DELISTED
Athenahealth, Inc.
ATHN
| $2.15M | 0.3% |
+18,000
| New | +$2.15M |
|
81
Dentsply Sirona
XRAY
$2.85B
| $2.14M | 0.3% |
+42,000
| New | +$2.14M |
|
82
DaVita
DVA
$9.85B
| $2.11M | 0.29% |
+26,000
| New | +$2.11M |
|
|
NUVA
83
DELISTED
NuVasive, Inc.
NUVA
| $2.07M | 0.29% |
+45,000
| New | +$2.07M |
|
84
Edwards Lifesciences
EW
$47.8B
| $2.07M | 0.29% |
+14,500
| New | +$2.07M |
|
85
iShares Biotechnology ETF
IBB
$5.6B
| $2.06M | 0.29% |
+6,000
| New | +$2.06M |
|
|
RLYP
86
DELISTED
RELYPSA INC COM
RLYP
| $1.98M | 0.28% |
+55,000
| New | +$1.98M |
|
|
MDCO
87
DELISTED
Medicines Co
MDCO
| $1.96M | 0.27% |
+70,000
| New | +$1.96M |
|
|
HTWR
88
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $1.93M | 0.27% |
+22,000
| New | +$1.93M |
|
|
XENT
89
DELISTED
Intersect ENT, Inc
XENT
| $1.91M | 0.27% |
+73,800
| New | +$1.91M |
|
90
Steris
STE
$24.1B
| $1.9M | 0.26% |
+27,000
| New | +$1.9M |
|
|
ICPT
91
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.83M | 0.26% |
+6,500
| New | +$1.83M |
|
92
AngioDynamics
ANGO
$417M
| $1.78M | 0.25% |
+100,000
| New | +$1.78M |
|
|
OCR
93
DELISTED
OMNICARE INC
OCR
| $1.77M | 0.25% |
+23,000
| New | +$1.77M |
|
94
AbbVie
ABBV
$372B
| $1.76M | 0.25% |
+30,000
| New | +$1.76M |
|
95
Insulet
PODD
$23.9B
| $1.75M | 0.24% |
+52,500
| New | +$1.75M |
|
96
Thermo Fisher Scientific
TMO
$186B
| $1.75M | 0.24% |
+13,000
| New | +$1.75M |
|
|
BLUE
97
DELISTED
bluebird bio
BLUE
| $1.69M | 0.24% |
+14,000
| New | +$1.69M |
|
98
Masimo
MASI
$7.59B
| $1.65M | 0.23% |
+50,000
| New | +$1.65M |
|
99
Danaher
DHR
$147B
| $1.61M | 0.23% |
+19,000
| New | +$1.61M |
|
100
United Therapeutics
UTHR
$13.8B
| $1.6M | 0.22% |
+9,300
| New | +$1.6M |
|